Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SERA PROGNOSTICS, INC. Director's Dealing 2022

Jul 19, 2022

34084_dirs_2022-07-19_2f0c182f-43c1-47cd-8fc2-de8708503b5e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SERA PROGNOSTICS, INC. (SERA)
CIK: 0001534969
Period of Report: 2022-07-18

Reporting Person: Blue Ox Healthcare Partners, LLC (10% Owner)
Reporting Person: Blue Ox Healthcare Partners SP, LLC (10% Owner)
Reporting Person: BXHCP SP II, LLC (10% Owner)
Reporting Person: BXHCP SP III, LLC (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-07-18 Class A Common Stock J 1383094 Disposed 132501 Indirect
2022-07-18 Class A Common Stock J 997627 Disposed 77420 Indirect
2022-07-18 Class A Common Stock J 1157764 Disposed 46744 Indirect

Footnotes

F1: Shares have been distributed pro rata for no consideration to certain members of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC in accordance with the required distribution of marketable securities stipulation in the respective Limited Liability Company Agreements.

F2: Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares.